Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
Archive

All stories

1,067 stories in Industry · Page 54 of 54

Wednesday, May 27 · 16 stories

  1. Industry

    Nurse Convicted in Fatal Drug Error Advocates for Hospital Safety Improvements

    RaDonda Vaught, a nurse convicted of negligent homicide for accidentally dispensing a deadly drug to a patient, now speaks publicly about hospital safety in the era of automation and AI. Her case highlights systemic issues in medication safety protocols that could affect patient care quality in Medicaid managed care networks. Healthcare organizations are increasingly focused on preventing similar incidents through improved safety systems and technology. This case serves as a reminder for MCOs to ensure their provider networks maintain robust medication safety protocols and error prevention systems.

    KFF Health News · 178 days ago
  2. Industry

    Trump Stock Purchase in Eli Lilly Raises Conflict Questions

    Former President Trump purchased stock in Eli Lilly while his administration implemented policies that benefited the pharmaceutical company. The investment timing coincided with regulatory decisions favorable to drugmakers. This highlights ongoing concerns about potential conflicts of interest between policymakers and pharmaceutical companies. Medicaid managed care organizations should monitor how political relationships may influence drug pricing and coverage policies.

    KFF Health News · 178 days ago
  3. Industry

    Researchers Identify Medical Routines Older Adults May Not Need

    New research identifies additional medical screenings and treatments that may provide limited benefit for older patients. The findings could influence clinical guidelines and coverage decisions for Medicare Advantage and dual-eligible special needs plans. Healthcare providers and managed care organizations serving older populations should review their care protocols and utilization management policies. The research adds to growing evidence supporting age-appropriate care that avoids unnecessary interventions for elderly beneficiaries.

    KFF Health News · 178 days ago
  4. Industry

    KFF CEO Drew Altman Announces Retirement, Larry Levitt and Mollyann Brodie Named Successors

    Drew Altman, founding CEO of KFF (Kaiser Family Foundation), announced his retirement after nearly 40 years leading the health policy research organization. Larry Levitt and Mollyann Brodie will assume joint leadership roles in 2024, bringing six decades of combined experience at KFF. The transition affects one of the most influential health policy research organizations that regularly produces Medicaid analysis, polling, and policy briefs. The leadership change may influence the organization's future research priorities and policy positions on Medicaid managed care issues.

    KFF Research · 178 days ago
  5. Industry

    HCA Healthcare Scales AI Across Clinical Operations with Clinician-Led Development

    HCA Healthcare has implemented AI solutions across its health system operations through a systematic approach involving clinician engagement from development through deployment. The health system focuses on careful testing and customization of AI tools for clinical care and hospital operations, with nurses and physicians serving as primary end users throughout the process. This represents a scaled approach to healthcare AI implementation that other health systems and managed care organizations are watching for operational efficiency and care quality improvements. The initiative demonstrates how large healthcare organizations are integrating AI into everyday clinical workflows.

    KFF Research · 178 days ago
  6. Industry

    NASHP Hosts Webinar on Private Equity Hospital Ownership Analysis

    The National Academy for State Health Policy will host a state-only webinar examining private equity ownership patterns in hospitals and provider groups across four states on May 19. The analysis focuses on ownership structures that could affect provider networks and care delivery. State officials will review findings relevant to network adequacy monitoring and provider stability oversight. The research provides insights for states managing Medicaid managed care networks where private equity-backed providers participate.

    NASHP · 178 days ago
  7. Industry

    FDA Extends Decision Deadline for AstraZeneca Breast Cancer Drug After Advisory Panel Opposition

    The FDA has extended the decision deadline for AstraZeneca's experimental breast cancer pill following an advisory panel's negative vote on the drug's approval. The delay affects potential formulary decisions for Medicaid managed care organizations that cover cancer treatments. Medicaid MCOs should monitor the FDA's final decision timeline as it will impact prior authorization protocols and specialty pharmacy networks for oncology services. The extension creates uncertainty for health plans developing 2024 drug coverage policies.

    STAT News · 178 days ago

Get the daily briefing.